Tencent Music Entertainment Group (TME) Announces Board Changes

Tencent Music Entertainment Group ("TME", or the "Company") (NYSE: TME and HKEX: 1698), the leading online music and audio entertainment platform in China, today announced the retirement of Mr. Matthew Yun Ming Cheng from his position as a director on the Board of Directors (the "Board"), effective February 28, 2025. Concurrently, the Board approved the appointment of Mr. Wai Yip Tsang, as a director on the Board, effective February 28, 2025.

"Matthew has been a valuable member of TME's Board during his tenure since 2022. On behalf of the Board, I would like to thank him for his dedication, which helped us drive growth and innovation while promoting the prosperity of China's music industry," commented Mr. Cussion Pang, Executive Chairman of TME. "I would also like to welcome Wai Yip to the Board. His deep financial background, extensive experience and business insights will be a tremendous asset to TME."

Mr. Tsang currently serves as the Financial Controller of Tencent Holdings Limited (HKEX: 0700). Prior to joining Tencent in 2014, Mr. Tsang began his career at PricewaterhouseCoopers and subsequently held senior financial positions, including chief financial officer or group financial controller at several companies listed on the Main Board of the Hong Kong Stock Exchange and the New York Stock Exchange, and served as a director of a company listed on the New Zealand Stock Exchange. Mr. Tsang is a fellow member of the Institute of Chartered Accountants in England and Wales, the Hong Kong Institute of Certified Public Accountants, and the Association of Chartered Certified Accountants, as well as a member of CPA Australia. He holds a Bachelor of Arts (Honors) in Accountancy. Mr. Tsang possesses extensive experience in audit, accounting, investor relations, and corporate finance, including initial public offerings, restructuring, and mergers and acquisitions activities.

You May Also Be Interested In

• Two Harbors rejects UWM Holdings lawsuit amid pending CrossCountry deal
• Berenberg Downgrades Novo Nordisk (NVO) to Hold
• Align Technology wins China patent case against Angelalign, gets RMB 10M